Segments - North America Remote Patient Monitoring Systems Market by Type of Devices (Breath Monitor, Heart Monitor, Multi-parameter Monitor, Hematology Monitor, and Others), Applications (Sleep Disorder, Diabetes Treatment, Cancer Treatment, Weight Management & Fitness Monitoring, Cardiovascular Diseases, and Others), End-users (Hospital/Clinics, Home Care Settings, and Others), and Geography (The US, Canada, Mexico, and Rest of North America) - North America Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The North America Remote Patient Monitoring Systems Market size was valued at USD 15.13 Billion in 2022 and is likely reach to USD 173.09 Billion by 2031, expanding at a CAGR of 31.1% during the forecast period, 2023 – 2031. The growth of the market is attributed to growing geriatric population and increasing demand for home-based monitoring devices.
Remote patient monitoring is a technology that collects medical data from the patients and transmit it electronically to the healthcare provider at remote location. The technology is capable of distance monitoring and analyzing physiological parameters such as blood oxygen levels, heart rate, blood pressure, blood sugar level, and vital signs.
The remote monitoring devices have improved the quality of care, patient convenience, and allow early prediction of aggravations and exacerbations. The increasing adoption of remote monitors has reduced the number of emergency department visits, and duration of hospitalization.
The high risk of developing chronic disease due to rapid urbanization and demand for improved healthcare systems has greatly influenced the manufacturing of remote monitoring systems.
The patients suffering from chronic diseases are advised to avoid physical visits to hospitals owing to the threat of getting infected, which has led hospitals to implement a remote patient monitoring systems to keep track of a patient’s health from distance.
The remote monitoring facilities have greatly reduced the expenditures on hospital visits by identifying small changes in the physiological health-related data of the patients due to self-monitoring.
Furthermore, the advanced monitoring systems have prevented avoidable hospitalizations and reduced travel expenses to receive quality medical care. Therefore, the proper implementation of remote monitoring technologies can expand access to quality healthcare, prevent spread of infection, decrease medical expenditure, assist during emergency, and save time.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The nationwide lockdowns and stringent regulations increased the demand for home-based medical facilities.
The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems for the patients having diabetes, cancer, and respiratory disorders.
Therefore, the high adoption of the telemedicine practices in order to treat the patients remotely has fuel the expansion of the market. Furthermore, the outbreak of coronavirus disease has resulted in long-term association between healthcare and non-healthcare industries to manufacture advanced integrated monitoring devices. This resulted into many opportunities for the expansion of the remote patient monitoring systems market.
Increasing hospitalization of middle-aged patients suffering from cancer, diabetes, and respiratory disorders is anticipated to drive the market growth during the forecast period.
Growing technological advancements for breath and heart monitors owing to increasing disposable income is expected to boost the market expansion during the projected period.
Rising incidence of chronic diseases due to the lifestyle changes and increasing population are anticipated to spur the market growth in the coming years.
High manufacturing costs, large number of under diagnosed patients, and lack of awareness is expected to hamper the market growth during the forecast period.
Government support, growing research & development activities for technological advancement, and rising demand for affordable home care therapeutic devices are expected to create numerous opportunities for the market growth during the forecast period.
The report on the North America remote patient monitoring systems market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Remote Patient Monitoring Systems Market -North America Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type of Devices (Breath Monitor, Heart Monitor, Multi-parameter Monitor, Hematology Monitor, and Others), Applications (Sleep Disorder, Diabetes Treatment, Cancer Treatment, Weight Management & Fitness Monitoring, Cardiovascular Diseases, and Others), and End-users (Hospital/Clinics, Home Care Settings, and Others) |
Geographical Scope |
The US, Canada, Mexico, and Rest of North America |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Medtronic PLC; Boston Scientific; Abbott Laboratories; Koninklijke Philips N.V.; and GE Healthcare |
Based on type of devices, the market is segregated into breath monitors, heart monitors, multi-parameter monitors, hematology monitors, and others. The heart monitors segment is projected to expand at a considerable CAGR during the forecast period owing to the rising prevalence of heart diseases and consequent increasing death rate among middle-age population.
Moreover, the large scale adoption of preventive care facilities is expected to increase the demand for heart rate monitors at a rapid pace in the coming years.
On the other hand, the breath monitors segment is anticipated to hold a considerable market share in coming years owing to increasing chronic respiratory diseases due to rising pollution, reduced air quality, smoking, and regular chemical interactions.
Furthermore, increasing asthmatic patients, rising demand for advanced monitors, and integration of technology such as machine learning & signal analysis are key factors that are anticipated to expand the growth of the market segment in the coming years.
On the basis of applications, the market is segmented into sleep disorder, diabetes treatment, cancer treatment, weight management & fitness monitoring, cardiovascular diseases, and others. The cancer treatment segment is expected to grow at a rapid pace during the projected period due the rising number of cancer cases and growing aging population.
Additional, the increasing government initiatives and high demand for personalized medicine are the major factors that aid in the growth of the market segment in the coming years.
However, the cardiovascular diseases segment is anticipated to exhibit a substantial growth during the forecast period owing to the increasing death rate of ischemic heart disease patients. Furthermore, the rising improvements in the technologies used in the development of cardiology devices, resulting in exponential monitoring outcomes, is expected to encourage the growth of the market segment during the forecast period.
Based on end-users, the market is divided into hospital/clinics, home care settings, and others. The home care settings segment is anticipated to constitute a major market share during the forecast period owing to the safe, cost-effective, convenient, and suitable environment provided by home care settings to the patients.
Furthermore, the high adoption of oxygen-related products in home medical equipment due to significant increase in incidence of chronic obstructive pulmonary diseases is estimated to fuel the growth of the market in the coming years.
On the other hand, the hospital/clinics segment is anticipated to exhibit a substantial growth during the projected period owing to the rising emphasis on effective and early disease diagnosis in hospitals and growing procedural volume in hospital settings.
Moreover, the high budget of hospitals for introducing various technologically advanced monitoring devices to meet the increasing demand is projected to boost the market growth in the upcoming years.
In terms of geography, the market is classified as The US, Canada, Mexico, and Rest of North America. The US market is anticipated to constitute a key share of the market during the projected period owing to the increasing incidence of chronic diseases and rising demand for wireless & portable systems in the country.
Moreover, the presence of reimbursement structures and high demand for cost-effective medical treatments are the major reasons to propel the expansion of the market in the coming years.
However, the market in Canada is anticipated to exhibit a robust CAGR during the forecast period due to growing technological advancements to meet the demand for home care devices. Additionally, increasing hospitalization of middle-aged population with sleeping & respiratory disorders is expected to spur the market expansion during the projected timeline.
Key players competing in the North America remote patient monitoring systems market are Medtronic PLC; Boston Scientific; Abbott Laboratories; Koninklijke Philips N.V.; and GE Healthcare. Companies are focusing on business strategies, long-term agreements, and collaborating with each other to incorporate remote patient monitoring functionalities in their devices.